Finance entity
earnings is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Justin Renz, the most common co-covered peer. Source depth averages 2 original sources per story, versus 2.6 across the same-window beat baseline.
Last mentioned: Mar 8, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
earnings is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Justin Renz, the most common co-covered peer. Source depth averages 2 original sources per story, versus 2.6 across the same-window beat baseline. Their average consequence score of 5 runs below the beat's 6.4 for that window. Zevra Therapeutics, Inc. appears in 1 tracked Finance story from March 8, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 55 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Zevra Therapeutics, Inc.. Shared-story counts are live from our verified record — not editorial picks.
Earnings Previews
Seeking Alpha releases Q4 2025 previews for both Voyager and Zevra.
CFO Appointment
Zevra Therapeutics names Justin Renz as Chief Financial Officer.
Voyager Partnership Update
Voyager reports progress on TRACER platform milestones with Novartis.
Miplyffa Approval
Zevra receives FDA approval for arimoclomol in NPC.
Voyager Technologies and Zevra Therapeutics are set to report Q4 2025 results, highlighting a pivotal shift from clinical development to commercial execution and platform validation. Investors are focused on Zevra's Miplyffa launch trajectory and Voyager's CNS-focused partnership revenue.
Zevra Therapeutics, Inc. is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
